KELIX bio, owned by Mubadala Investment Company, has announced that it has completed the acquisition of DiabTec LLC, a subsidiary of Julphar.

The Persian Gulf Pharmaceutical Industries, the leading pharmaceutical power plant in the MENA region, published its financial results for the second quarter of Q2) and the first half of H1 (2024), which sold 883 million dirhams.